DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183316

Serum progesterone levels on the day of hCG trigger and ICSI outcome: a retrospective observational cohort study

Kinnari Vilaschandra Amin, Purnima Nadkarni, Pooja Nadkarni Singh, Prabhakar Singh

Abstract


Background: Whether serum progesterone (P4) level on the day of human chorionic gonadotropin (hCG) trigger is related to the outcome of artificial reproductive technology (ART) is still a debatable issue. The objective of this study was to evaluate relationship between serum Progesterone levels on the day of hCG trigger and ICSI outcome.

Method: This was a retrospective, non-interventional, observational, cohort study of patients undergoing ICSI at 21st Century Group of Hospitals, Killa Pardi and Surat, Gujarat during the period of January 2018 to March 2018. Patients with age group of 20-40 years who underwent ICSI-ET using GnRH antagonist flexible protocol during this period, had obtained 2 or more MII oocytes during retrieval and had at least one grade I embryo transferred were included in this study. Women using donor oocytes were excluded. Serum progesterone levels were analysed on day of hCG trigger. Total 165 patients were included in the study. They were divided into two groups, those with β-hCG less than or equal to 1.5 ng/ml and those with β-hCG more than 1.5 ng/ml. Student's t test and Chi square test were used to compare the clinical pregnancy rates between two groups.

Results: Clinical pregnancy rate decreases with increase in serum progesterone levels on the day of hCG trigger. Patients with serum progesterone levels ≤1.5 ng/ml had significantly higher clinical pregnancy rates than those with progesterone levels >1.5 ng/ml (45% vs 6%; p :<0.001).

Conclusion: Pre-hCG rise in serum Progesterone concentration does not affect the oocyte quality. But, it significantly decreases the chances of implantation and the clinical pregnancy rates.


Keywords


hCG trigger, ICSI, Progesterone levels, Pregnancy

Full Text:

PDF

References


Corti L, Papaleo E, Pagliardini L, Rabellotti E, Molgora M, La Marca A, et al. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law. Eur J Obstet Gynecol Reprod Biol. 2013;171:73-7.

Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60000 cycles. Hum Reprod Update. 2013;19:433-57.

Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles. Fertil Steril. 2012;97:1321-7.

Elgindy EA. Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy. Fertil Steril. 2011;95:1639-44.

Kilicdag EB, Haydardedeoglu B, Cok T, Hacivelioglu SO, Bagis T. Premature progesterone elevation impairs implantation and live birth rates in GnRH agonist IVF/ICSI cycles. Arch Gynecol Obstet. 2010;281:747-52.

Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update. 2007;13:343-55.

Martinez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, et al. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online. 2004;8:183-90.

Houmard BS, Ball D, Soules MR. Elevated serum progesterone levels on the day of trigger do not adversely affect pregnancy rates: a prospective blinded evaluation in 384 consecutive IVF cycles. Fertil Steril. 2014;101:e10-11.

Gunderson S, Anderson K, Riley J. Progesterone value on day of HCG trigger is not associated with outcomes from fresh embryo transfer. Fertil Steril. 2018;109:e29-30.

Tsai, Yi-Ru. Progesterone elevation on the day of human chorionic gonadotropin administration is not the only factor determining outcomes of in vitro fertilization. Fertil Steril. 2015;103:106-11.

Larcher SJM, Ganzer LM, Maccari VM. Clinical pregnancy rates according to the serum progesterone level on the human chorionic gonadotropin day. Fertil Steril. 2016;106:e200.

Swati G, Surbhi TS, Deepa LM. Progestrone level on the day of hCG trigger and IVF outcomes: an observational study. IJBAMR. 2016;6(1):682-6.

Kasum M, Radakovic B, Simunic V, Oreškovic S. Preovulatory progesterone rise during ovarian stimulation for IVF. Gynecol Endocrinol. 2013;29(8):744-8.

Haouzi D, Bissonnette L. Endometrial receptivity profile in patients with premature progesterone elevation on the day of hCG administration. BioMed Res Int. 2014;2014.

Papanikolaou EG, Kolibianakis EM, Pozzobon C, Tank P, Tournaye H, Bourgain C, et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril. 2009;91:949-52.

Ochsenkuhn R, Arzberger A, von Schonfeldt V, Gallwas J, Rogenhofer N, Crispin A, et al. Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers. Fertil Steril. 2012;98:347-54.

Vaerenbergh VI, Fatemi HM, Blockeel C. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online. 2011;22(3):263-71.

Schoolcraft W, Sinton, E, Schlenker, T, Huynh, D, Hamilton F, Meldrum, D. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril. 1991;55:563-6.

Fanchin R, de Zeigler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril. 1993;59:1090-4.

Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25(8):2092-100.

Li M, Xie Y, Park H, Kumar A, Hubert G, Buyalos R. The effects of elevated serum progesterone level at the day of hCG injection on clinical outcome in IVF-ET patients. Fertil Steril. 2013;100(3):S7.